Tonix Pharmaceuticals Holding Corp Stock Nasdaq
Stocks
US8902604094
Pharmaceuticals
| Market Cap | 184M 158M 146M 137M 257M 17.36B 259M 1.72B 673M 8.5B 689M 675M 29.41B | P/E Ratio 2026 * |
-1.11x | P/E Ratio 2027 * | -1.85x |
|---|---|---|---|---|---|
| Enterprise Value | 184M 158M 146M 137M 257M 17.36B 259M 1.72B 673M 8.5B 689M 675M 29.41B | EV / Sales 2026 * |
5.94x | EV / Sales 2027 * | 2.27x |
| Free-Float |
99.87% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Tonix Pharmaceuticals Holding Corp
| 1 day | +83.42% |
| Manager | Title | Age | Since |
|---|---|---|---|
Seth Lederman
CEO | Chief Executive Officer | 68 | 2007-11-15 |
Bradley Saenger
DFI | Director of Finance/CFO | 52 | 2016-01-31 |
Errol Gould
CTO | Chief Tech/Sci/R&D Officer | - | 2024-12-02 |
| Director | Title | Age | Since |
|---|---|---|---|
David Grange
BRD | Director/Board Member | 78 | 2018-02-12 |
Richard Bagger
BRD | Director/Board Member | 66 | 2020-06-08 |
Adeoye Olukotun
BRD | Director/Board Member | 81 | 2018-09-04 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +83.42% | -17.57% | - | - | 184M | |
| -0.32% | -1.72% | +37.83% | +148.79% | 1,007B | |
| -2.16% | +1.51% | +50.01% | +43.93% | 567B | |
| -2.70% | -0.66% | +15.97% | +63.07% | 392B | |
| -0.72% | +1.05% | +20.91% | +18.37% | 328B | |
| -0.64% | +0.96% | +24.02% | +31.69% | 277B | |
| +0.09% | -3.11% | +22.10% | +12.05% | 275B | |
| -0.81% | +5.10% | -43.13% | -48.68% | 196B | |
| -1.31% | +1.39% | +18.74% | +53.45% | 189B | |
| -1.03% | -2.97% | +13.02% | +57.34% | 154B | |
| Average | +7.45% | +0.33% | +17.72% | +42.22% | 376.23B | |
| Weighted average by Cap. | -0.79% | -0.03% | +26.40% | +67.04% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 30.91M 26.64M 24.52M 23M 43.21M 2.92B 43.64M 290M 113M 1.43B 116M 114M 4.95B | 80.91M 69.74M 64.18M 60.21M 113M 7.65B 114M 759M 296M 3.74B 304M 297M 12.96B |
| Net income | -176M -152M -140M -131M -246M -16.63B -248M -1.65B -645M -8.14B -660M -646M -28.18B | -141M -121M -112M -105M -197M -13.3B -199M -1.32B -516M -6.51B -528M -517M -22.54B |
| Net Debt | - | - |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
